Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
SPRUCE BIOSCIENCES, INC. (SPRB)
|
Add to portfolio |
|
|
|
| Price: |
$4.22
| | Metrics |
| OS: |
40.7
|
M
| |
-53
|
% ROE
|
| Market cap: |
$172
|
M
| |
-444
|
% ROIC
|
|
Net cash:
|
$116
|
M
| |
$2.86
|
per share
|
|
EV:
|
$55.4
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
($54.3)
|
M
| |
|
|
| EPS |
($1.43)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 0.0 | 35.2 | 0.0 | 30.7 | 0.0 | 0.0 | 8.4 |
| Revenue growth | | 14.7% | | | | -100.0% | |
| Cost of goods sold | 0.0 | 47.3 | 0.0 | 42.1 | 0.0 | 0.0 | 10.0 |
| Gross profit | 0.0 | -12.1 | 0.0 | -11.4 | 0.0 | 0.0 | -1.6 |
| Gross margin | | -34.3% | | -37.0% | | | -18.7% |
| Research and development | 35.2 | | 30.7 | | 23.9 | 10.8 | |
| General and administrative | 12.1 | 12.1 | 11.4 | 11.4 | 5.6 | 2.3 | 1.6 |
| EBIT | -47.3 | -47.3 | -42.1 | -42.1 | -29.4 | -13.1 | -10.0 |
| EBIT margin | | -134.3% | | -137.0% | | | -118.7% |
| Pre-tax income | -46.2 | -46.2 | -42.3 | -42.3 | -29.5 | -13.1 | -9.9 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -46.2 | -46.2 | -42.3 | -42.3 | -29.5 | -13.1 | -9.9 |
| Net margin | | -131.2% | | -137.8% | | | -117.3% |
| |
| Diluted EPS | ($1.96) | ($1.96) | ($1.81) | ($1.81) | ($4.93) | ($17.12) | ($13.12) |
| Shares outstanding (diluted) | 23.5 | 23.5 | 23.4 | 23.4 | 6.0 | 0.8 | 0.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|